Literature DB >> 2242956

Antibody-mediated cytotoxic effects in vitro and in vivo of rat cells on infective larvae of Brugia malayi.

R Chandrashekar1, U R Rao, D Subrahmanyam.   

Abstract

Albino rat macrophages and neutrophils in the presence of immune serum adhered to and promoted killing of Brugia malayi infective larvae in vitro. At a similar cell-target ratio, macrophages were more potent than neutrophils in inducing cytotoxic response to the larvae. Eosinophils were also effective in killing but only at a high cell-target ratio. The activity in the immune serum could be absorbed to and eluted from a Protein A-Sepharose column suggesting involvement of IgG antibody in the reaction. An indirect fluorescent antibody test confirmed the presence of IgG on the surface of larvae incubated in immune serum. Infective larvae were attacked by host cells within micropore chambers 16-24 h after implantation into immunized rats. Further, a strong cytotoxic response to the larvae was seen when they were introduced intraperitoneally into immune rats indicating the role of antibody and cells in vivo. We suggest that antibody-dependent cellular cytotoxicity may represent an important mechanism of parasite killing in an immune host.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242956     DOI: 10.1016/0020-7519(90)90005-8

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  12 in total

1.  Major basic protein from eosinophils and myeloperoxidase from neutrophils are required for protective immunity to Strongyloides stercoralis in mice.

Authors:  Amy E O'Connell; Jessica A Hess; Gilberto A Santiago; Thomas J Nolan; James B Lok; James J Lee; David Abraham
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

2.  Multivalent vaccine formulation with BmVAL-1 and BmALT-2 confer significant protection against challenge infections with Brugia malayi in mice and jirds.

Authors:  Ramaswamy Kalyanasundaram; Padmavathi Balumuri
Journal:  Res Rep Trop Med       Date:  2011-03

3.  B-cell deficiency suppresses vaccine-induced protection against murine filariasis but does not increase the recovery rate for primary infection.

Authors:  C Martin; M Saeftel; P N Vuong; S Babayan; K Fischer; O Bain; A Hoerauf
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval strongyloides stercoralis in mice.

Authors:  Ann Marie Galioto; Jessica A Hess; Thomas J Nolan; Gerhard A Schad; James J Lee; David Abraham
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection.

Authors:  Sabine Specht; Michael Saeftel; Manuela Arndt; Elmar Endl; Bettina Dubben; Nancy A Lee; James J Lee; Achim Hoerauf
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

6.  Multivalent fusion protein vaccine for lymphatic filariasis.

Authors:  Gajalakshmi Dakshinamoorthy; Abhilash Kumble Samykutty; Gnanasekar Munirathinam; Maryada Venkatarami Reddy; Ramaswamy Kalyanasundaram
Journal:  Vaccine       Date:  2012-10-02       Impact factor: 3.641

7.  Troponin 1 of human filarial parasite Brugia malayi: cDNA cloning, expression, purification, and its immunoprophylactic potential.

Authors:  Vikas Kushwaha; Prachi Tewari; Payal Mandal; Anurag Tripathi; P Kalpana Murthy
Journal:  Parasitol Res       Date:  2019-05-04       Impact factor: 2.289

8.  T cells are required for host protection against Brugia malayi but need not produce or respond to interleukin-4.

Authors:  L Spencer; L Shultz; T V Rajan
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis.

Authors:  S K Joseph; K Ramaswamy
Journal:  Vaccine       Date:  2013-06-02       Impact factor: 3.641

10.  Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis.

Authors:  Anandharaman Veerapathran; Gajalakshmi Dakshinamoorthy; Munirathinam Gnanasekar; Maryada Venkata Rami Reddy; Ramaswamy Kalyanasundaram
Journal:  PLoS Negl Trop Dis       Date:  2009-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.